Role of Endothelin-1 and Nitric Oxide in Acute Ischemic Stroke Leptomeningeal Collateral Activation
Authors:
- Marta IacobucciMIMarta Iacobucci
- Angela RisitanoARAngela Risitano
- Paolo AmisanoPAPaolo Amisano
- Irene BertoIBIrene Berto
- Roberto CarnevaleRoberto Carnevale
- Vittoria CammisottoVCVittoria Cammisotto
- Francesco BiraschiFBFrancesco Biraschi
- Carlo CirelliCCCarlo Cirelli
- Maria Teresa Di MascioMMMaria Teresa Di Mascio
- Danilo ToniDTDanilo Toni
- Svetlana LorenzanoSLSvetlana Lorenzano
- Manuela De MicheleMMManuela De Michele
Open Access
- 30 March 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (7) , 3205
Abstract
Good leptomeningeal collaterals (LMCs) after large vessel occlusion (LVO) extend the time window for endovascular therapy. The mechanisms regulating LMC activation are not fully understood. The aim of this study was to investigate the potential role of two vasoactive molecules endothelin-1 (ET-1)—a vasoconstrictor agent—and nitric oxide (NO)—a vasodilator agent—in the regulation of post-stroke LMCs. Ischemic stroke patients within 6 h of LVO were included. Collateral status was assessed using the Menon scoring system based on computed tomography angiography scans. Patients were accordingly divided into three groups: poor, intermediate, and good LMCs. Recanalization was evaluated using the modified thrombolysis in cerebral infarction (mTICI) score. Serum levels of ET-1 and NO were measured at three time points: T0 (p = 0.030). A significant linear positive correlation was revealed at T0 between high levels of ET-1 and the neutrophil count (Spearman’s rho = 0.236, p = 0.035). Subgroup analysis showed a significant inverse correlation at T1 between NO and the collateral score (Spearman’s rho = −0.251, p = 0.021). Although we observed no significant association between LMC score and serum ET-1 concentrations, at 24 h higher ET-1 serum levels were predictive of poor outcome and higher NO levels were correlated with poor collateral status. These findings may indicate an inadequate microvascular reperfusion, possibly due to ET-1-mediated vasoconstriction, neutrophil activation, and NO-mediated oxidative stress, suggesting their potential role in the no-reflow phenomenon.Keywords
All Related Versions
Funding Information
- Sapienza Università di Roma (AR120172B783068D)
This publication has 39 references indexed in Scilit:
- Nitric oxide signaling in health and diseaseCell, 2022
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and InfarctNew England Journal of Medicine, 2018
- The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and DiseaseNeuron, 2017
- Nitric oxide inhibits the production of soluble endothelin converting enzyme-1Molecular and Cellular Biochemistry, 2014
- Endothelins in health and diseaseEuropean Journal of Internal Medicine, 2007
- Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor κBClinical Science, 2002
- Neurophysiological investigation of the basis of the fMRI signalNature, 2001
- Physiological antagonism of endothelin‐1 in human conductance and resistance coronary arteryBritish Journal of Pharmacology, 2001
- Nitric Oxide Synthase Inhibition and Cerebrovascular RegulationJournal of Cerebral Blood Flow & Metabolism, 1994
- Big-endothelin in acute ischemic strokeJournal of Stroke and Cerebrovascular Diseases, 1993